Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway
Biochemical and Biophysical Research Communications · 2024-05 · 707 · 149781
DOI: 10.1016/j.bbrc.2024.149781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-05. Verfasst von Enze Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Lipid Research & Chongqing Key Laboratory of Metabolism on Lipid and Glucose, Key Laboratory of Molecular Biology for Infectious Diseases …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms, Blood Platelet Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Chongqing Municipal Education Commission, Chongqing Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND & AIMS: CD36, a membrane protein widely present in various tissues, is crucial role in regulating energy metabolism. The rise of HCC as a notable outcome of NAFLD is becoming more apparent. Patients with hereditary CD36 deficiency are at increased risk of NAFLD. However, the impact of CD36 deficiency on NAFLD-HCC remains unclear. METHODS: Global CD36 knockout mice (CD36KO) and wild type mice (WT) were induced to establish NAFLD-HCC model by N-nitrosodiethylamine (DEN) plus high fat diet (HFD). Transcriptomics was employed to examine genes that were expressed differentially. RESULTS: Compared to WT mice, CD36KO mice showed more severe HFD-induced liver issues and increased tumor malignancy. The MEK1/2-ERK1/2 pathway activation was detected in the liver tissues of CD36KO mice using RNA sequencing and Western blot analysis. CONCLUSION: Systemic loss of CD36 leaded to the advancement of NAFLD to HCC by causing lipid disorders and metabolic inflammation, a process that involves the activation of MAPK signaling pathway. We found that CD36 contributes significantly to the maintenance of metabolic homeostasis in NAFLD-HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Lipid Research & Chongqing Key Laboratory of Metabolism on Lipid and Glucose, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of…
Förderung
- Chongqing Municipal Education Commission
- Chongqing Medical University
- National Natural Science Foundation of China
Zitieren
APA
Zheng, E., Chen, Q., Xiao, A., Luo, X., Lu, Q., Tian, C., Liu, H., Zhao, J., Wei, L., Yang, P., & Chen, Y. (2024). Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway. Biochemical and Biophysical Research Communications, 707, 149781. https://doi.org/10.1016/j.bbrc.2024.149781
Vancouver
Zheng E, Chen Q, Xiao A, Luo X, Lu Q, Tian C, et al. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway. Biochemical and Biophysical Research Communications. 2024;707:149781. doi:10.1016/j.bbrc.2024.149781
BibTeX
@article{Zheng2024,
author = {Zheng, Enze and Chen, Qianqian and Xiao, Anhua and Luo, Xiaoqing and Lu, Qiannan and Tian, Chuan and Liu, Huan and Zhao, Jinqing and Wei, Li and Yang, Ping and Chen, Yaxi},
title = {Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {707},
pages = {149781},
doi = {10.1016/j.bbrc.2024.149781}
}
EUVIMED